Integrated FHIT and IDH2 biomarker profiling predicts lethal sensitivity to DCPS inhibition in Acute Myeloid Leukemia and Myelodysplastic syndrome.

Discov Oncol · 2026 · PMC13065853 · PMID 41888450

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Indeed, HU-treated samples showed a trend towards decreased sensitivity to RG3039 despite unchanged FHIT expression levels (Supplementary Fig. 1A).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.